Repligen (NASDAQ:RGEN – Get Free Report) had its target price lifted by equities researchers at Wells Fargo & Company from $180.00 to $185.00 in a research report issued to clients and investors on Thursday,Benzinga reports. Wells Fargo & Company‘s price objective would indicate a potential upside of 30.26% from the stock’s current price. Evercore reaffirmed an “outperform” rating and issued a $160.00 target price on shares of Repligen in a report on Monday, July 6th. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.43. Get Repligen alerts:Check Out Our Latest Research Report on RepligenRepligen Stock Up 0.6%Shares of Repligen stock traded up $0.80 during trading hours on Thursday, hitting $142.03.